Skip to main content
. 2019 Mar 22;106(2):383–390. doi: 10.1002/cpt.1371

Figure 2.

Figure 2

Projected asthma exacerbation risk by treatment regimen, antidrug antibody (ADA) status, and age group from clinical trial simulations.a Q4W, every 4 weeks; Q8W, every 8 weeks. aOne hundred trial simulations with 500 patients for each scenario. bThe prediction interval for adolescents was wider than that for adults because of the smaller numbers enrolled in the SIROCCO and CALIMA trials compared with adult patients. [Colour figure can be viewed at wileyonlinelibrary.com]